EXOME: Biotech • Healthcare • Life Sciences

National
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More

1.
AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets | Boston
2.
3 Takeaways From the Resurrection of Biogen’s Alzheimer’s Drug | San Diego
3.
Acadia Looks to Expand Drug Beyond Parkinson’s Disease Psychosis | San Diego
4.
FDA Puts Partial Hold on Tests of Ipsen Drug Acquired in $1B Deal | National
5.
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More | National
6.
Biogen Points to Enrollment and Dosing to Explain Alzheimer’s Results | National

Learn about the Xconomists →

Bryony Winn

Bryony Winn

Chief Strategy and Innovation Officer, Blue Cross and Blue Shield of North Carolina

Digital Health Survivors & Innovative Incumbents Must Team Up for True Disruption

Rob Coppedge

Rob Coppedge

CEO of Echo Health Ventures

Partner or Die: How to Succeed Even After the Digital Health Hype Quiets Down

More Opinion, Insight, and Analysis ›

What’s Next in Neuroscience Therapies – Xconomy San Francisco Life Science Forum – Nov. 19, 2019

November 19, 2019

$9.7B

Novartis/The Medicines Company

Duke’s Jacob Jacobsen Joins Evecxia as Chief Scientific Officer

Akcea Therapeutics Appoints Alex Howarth Chief Operating Officer

FDA Rejects Enzyvant’s Regenerative Therapy for Rare Immune Disorder
Frank Vinluan | Boston
Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%
Frank Vinluan | Boston
As Alzheimer’s Conference Kicks Off, All Eyes Are on Biogen’s Drug
Sarah de Crescenzo | San Diego
6 Experimental Alzheimer’s Disease Diagnostics Projects Get Funding Boost
Sarah de Crescenzo | New York
Civetta Therapeutics Unveils a Propeller Protein Plan, $53M in Funding
Melissa Fassbender | Boston
FDA Green Lights Sight Diagnostics’ Finger-Prick Blood Test
Melissa Fassbender | National
Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck
Frank Vinluan | San Francisco
GHO Capital Raises Over $1bn, Eyes Biotech Outsourcing Services
Melissa Fassbender | National
Stemonix, Atomwise Team Up on Drug Discovery With MicroOrgans and AI
Sarah de Crescenzo | San Diego

Read More Posts ›

Underwriters and Partners

Xpertise: Watch + Learn

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Key indicators & expert insight from industry leaders
Xconomy

Tweets from https://twitter.com/Xconomy/lists/lifesci